InvestorsHub Logo
icon url

DaddyNewb

12/11/18 10:32 AM

#113364 RE: Volcano #113357

"Vivos Inc. has obtained an exclusive license to eight (8) patents related to RadioGel™ device technology for use in high-dose radiation therapy. The license was granted by *Battelle pursuant to an option between Battelle and Vivos announced in February 2011. The Agreement grants Vivos an exclusive license to make, have made, use and sell RadioGel™ as a device. Yttrium-90 is a well-established medical isotope with many applications in cancer treatment. The combination of insoluble Yttrium-90 particles and the polymer gel carrier offers physicians an opportunity to deliver a safe, effective treatment option at a low cost."




icon url

kayak_wench

12/11/18 10:49 AM

#113381 RE: Volcano #113357

What do you not believe?
Battelle bailing Vivos out (ADMD at the time) and at one time having 10% ownership of the company?
https://irdirect.net/prviewer/release/id/697819

That Vivos is allowed to market the technology via a yearly license (versus owning it)?
https://www.radiogel.com/radiogel/
(see third paragraph)

I'm thinking your not calling the news article where Battelle is again letting someone else bring their technology to market.